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THE HARVEY LECTURES, SERIES 77

THE MACROPHAGE-VERSATILE ELEMENT
OF INFLAMMATION*
ZANVIL A. COHN
Laboratory of Cellular Physiology and Immunology,
The Rockefeller University,
New York, New York
� URING the course of an inflammatory reaction, the system of
1-.Anononuclear phagocytes is involved in multiple and complex
tasks-from the initial signaling of other cellular elements to the de
struction of local tissues and ultimately to tissue remodeling and wound
repair. In this context they are also significant components of the nor
mal physiological process of cellular turnover and degradation as well
as diverse pathological events prominent in the chronic arthritides and
atherosclerosis.
To carry out these roles, bone marrow-derived cells must recognize,
and emigrate to, the peripheral tissues. They must initiate the interior
ization of environmental molecules of soluble and particulate nature and
respond to other signals that turn on secretory cycles. In this discussion
I review our current understanding of the mechanisms whereby this
·versatile element of inflammation carries out both beneficial and de
leterious tasks in mammalian hosts.
I. LIFE HISTORY: MAINTENANCE OF THE TISSUE COMPARTMENT
The nature of the pools and compartments of mononuclear pha
gocytes represents information of relatively recent origin (van Furth and
Cohn 1968; van Furth et al., 1972) and leads to the unitarian view that
heterogeneous tissue pools all arise from common progenitors in the
marrow (Fig. 1). Although our knowledge stems largely from small
laboratory rodents, the fragments of available information suggest that
similar kinetics obtain in man. Three facts distinguish their life history
*Lecture delivered February 18, 1982.
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FIG. I. Mononuclear phagocytes: pools and population (murine).

from that of other blood-borne phagocytes. First, the bone marrow pool
is relatively small, without significant storage of mature members of the
series. Second, the cell is released into the circulation in a relatively
immature form and matures or differentiates into a larger and more
active macrophage while exposed to the environmental stimuli of the
tissues. Finally, the life-span in the tissues is long, as the cell resides in
a G0 state and may undergo repeated cycles of endocytic and secretory
activity. It is likely that the macrophages in the perivascular connective
tissue outlining small blood vessels have half-lives much longer than
alveolar or Kupffer cells, which are constantly exposed to particulate
agents. What should be emphasized, however, is the large tissue pool
some 500-1000 times greater than the bone marrow compartment. Par
enchymal organs such as liver are particularly rich sources, and mac
rophages represent approximately 20-30% of the total cell number of
this huge organ. Such long-lived macrophages of the tissue pool there
fore represent a widely distributed in situ population poised, if you will,
for an immediate response to perturbations by noxious stimuli-a popu
lation that is soon joined by emigrating monocytes and younger ele
ments of the marrow compartment that swell local numbers, in part by
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replication. Under steady state conditions, monocytes leave the circula
tion randomly, whereas they are selectively focused into areas of in
flammation. In some instances, most of the daily production rate may
enter an active lesion, leaving secondary sites relatively deficient in
cells. This is also the result of the limited ability of the bone marrow
(twofold) to increase its supply of cells by reducing the generation time
and releasing more immature elements such as promonocytes.
II.

THE MIGRATORY EVENT

The flight of monocytes from the circulation and their entry into the
tissues occurs in a random fashion under steady state conditions and
rather selectively during inflammation. It entails initial recognition of
an endothelial cell surface, attachment, spreading, translational motility
and directed movement or chemotaxis, basement membrane penetra
tion, and fixation in the tissues. These multiple events are imperfectly
understood and represent important regulatory steps in the inflammatory
state. There are a number of products, however, that enhance the
spreading of monocytes and macrophages (Bianco et al., 1976, 1979;
Gotze et al., 1979) and may play a role in vivo. One of the best studied
is the large split product of factor B of the alternative pathway of
complement fixation. Factor Bb is a diisoprophyl fluorophosphate
(DFP)-inhibitable serine esterase that, at microgram levels, rapidly
spreads mononuclear phagocytes, inhibiting motility and in this sense
representing a defined macrophage inhibitory factor (MIF). It is of
interest that factor B is synthesized by macrophages and both secreted
and placed on the surface of the plasma membrane. Since many of the
spreading factors are proteinases (Rabinovitch and De Stefano, 1973),
the cleavage of factor B on the macrophage surface may be the common
denominator that controls attachment spreading and tissue localization.
A second molecule that initiates the attachment of macrophage is
fibronectin (Bevilacqua et al., 1981). Although macrophages, like
many other cells, synthesize fibronectin, they have on their surface a
receptor that recognizes this molecule. With the exposure of collagens
and the subsequent binding of plasma fibronectin during tissue injury,
the fibronectin receptor could play a significant role in many patholog
ical states leading to macrophage accumulation and perhaps granuloma
formation.
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III.

THE MACROPHAGE AS AN ENDOCYTIC CELL-THE
APPARATUS

VACUOLAR

The vacuolar apparatus of macrophages represents a particularly dy
namic series of organelles comprising the plasma membrane, endo
somes, and lysosomes. Considerable information has accrued over the
years concerning the regulation and packaging of acid hydrolases (Cohn
and Benson, 1965; Cohn et al., 1966). This information and the related
studies on the initiation and maintenance of pinocytosis and pha
gocytosis (reviewed in Silverstein et al., 1977) left us with knowledge
of lysosomal contents--enzymes, substrates, and hydrolysis-but few
insights into the membrane of the organelles and its composition, flux
es, and turnover.
Figure 2 and the accompanying expanded legend outlines in a sim-
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F1G. 2. Selected properties and dynamics of the vacuolar apparative of macrophages.
I. Plasma membrane: a. Surface area of resident, mouse peritoneal cell = 825 µ,m 2. b.
Total volume of resident, mouse peritoneal cell = 395 µ,m3. c. Fractional rate of internal
ization as pinocytic vesicles = 3.1 % of total surface area per minute. d. Membrane in
selectively labeled with soluble lactoperoxidase, 1251, glucose oxidase, glucose, method.
e. There are approximately 24 exteriorly disposed, iodinatable glycoproteins. f. Labeled
membrane proteins tum over synchronously with a half-life of± 25 hours. g. Monoclonal
antibodies recognize six distinctive membrane antigens. h. Both iodinatable polypeptides
and antigens (g) cycle from cell surface , through the vacuolar apparatus, and back to cell
surface as a unit. i. Endocytic receptors include two distinct FcRs, C 3bR, and mannose R.
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plified fashion the properties of the plasma membrane ( 1), pinocytic
vesicles (2), phagocytic vacuoles (3), and secondary lysosomes (4). A
more complete description can be found in a review (Cohn and Stein
man, 1982). Figure 2 stresses our current information on the recycling
and the reutilization of plasma membrane components as they flow from
j. Membrane influx is inversely correlated with saturation of membrane phospholipid fatty
acids. k. Arachidonic acid comprises 25% of total fatty acids. I. 5' -Nucleotidase and
phosphodistinase I are useful ectoenzyme markers.
2. Pinocytosis and pinocytic vesicles: a. Both fluid-phase and adsorptive pinocytosis
occur. b. Adsorptive vesicles exhibit clathrin coats. c. Average vesicle diameter = 0.202
µ,m. d. Average vesicle surface area = 0.196 µ,m 2. e. Average vesicle volume = 0.0143
µ,m3 . f. Percentage of total cell volume = 2.5%. g. Percentage of total surface area =
12.5%. h. Steady state number per cell = 250-1000. i. Activation energy for generation
= 18 kcal/mo!. j. Selectively labeling follows the fluid-phase uptake of an iodinating
system. k. Polypeptide composition is indistinguishable from that of plasma membrane. I.
Fluid phase vesicles are generated at a continuous and constant rate. m.· Vesicle fusion
with lysosomes is selectively inhibited with tetravalent concanavalin A. n. Rate of genera
tion is linear between 6 and 38°C. o. Increased saturation of fatty acids inhibits total
vesicle formation without modifying activation energy. p. Pinocytosis is not inhibited
with cytochalasin. q. It is focused into perinuclear zone by a saltatory flow mechanism.
3. Phagocytosis and phagocytic vacuoles: a. Phagocytosis is a discontinuous and lo
calized process. b. It is a receptor-mediated event-Fe , C3b, mannose. c. Vacuoles
conform to size and shape of particles < I to > 10 µ,m. d. Internalization requires the
circumferential flow of membrane, utilizing receptor-ligand interactions; ''zipper mecha
nism." e. Activation energy is 45 kcal/mo!. f. Phagocytosis consumes high energy stores
of creatine phosphate and ATP. g. Vacuoles are generated at temperatures only above 18
± 2°C. h. Vacuoles are transiently associated with clathrin. i. Vacuole generation is
inhibited with cytochalasin. j. Vacuoles fail to fuse with secondary lysosomes at tempera
tures below 18 ± 2°C. k. Increased saturation of membrane phosphatide fatty acids
decreases total particle internalization and elevates the activation energy for particle
uptake. I. Polystyrene latex (I. I µ,m) phagocytic vacuoles contain a representative sample
of plasma membrane polypeptides, antigens, and ectoenzymes.
4. Phagolysosomes (secondary lysosomes): a. Secondary lysosomes (2° Lys.) may
represent from 15 to 55% of the total cell surface area. b. Phagolysosomes are a fusion
product of primary and secondary lysosomes with endosomes. c. Size depends upon both
input of extracellular solutes and the rate of hydrolysis. d. Intravacuolar pH = 4. 7. e.
Contain ± 30 hydrolytic enzymes with acid pH optima. f. Membranes are permeable to
amino acids and selected dipeptides. g. Luminal surface of membrane is selectively
labeled with lactoperoxidase-latex bead iodinating systems. h. Labeled polypeptides
(iodinated) are indistinguishable from those of plasma membrane, phagocytic vacuole,
and pinocytic vesicle. i. Centrifugal flow of polypeptides of plasma membrane occurs
within 5 minutes of "recycling." j. Rapid and continuous contact with extracellular
medium is via pinocytic vesicles. k. Storage of macroanions leads to a selective block in
fusion with phagosomes but not pinosomes.
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the cell surface through the cytosol and then return to the surface after
delivering their contents to the digestive bodies or secondary lyso
somes. The basis for this scheme can be found in a number of papers,
which encompass stereological approaches,_ selective labeling of the
vacuolar organelles, and turnover of intrinsic membrane glycoproteins.
The initial information was derived from studies on the rate at which
fluid phase and adsorbed solutes were interiorized within pinocytic
vesicles (Steinman and Cohn, 1972a,b). These studies, at the biochemi
cal and ultrastructural level, emphasized the rapidity of both solute
interiorization and the rate of intralysosomal degradation. It was clear
that molecules adsorbed to the plasma membrane Fe receptor were
captured at rates 4 x 102 to 103 -fold greater than the fluid phase
reactants. Fluid phase uptake was a constant, constitutive nonsaturable
event, whereas adsorptive endocytosis exhibited saturation kinetics and
was discontinuous. It was not, however, until Steinman's careful ster
eological analysis that we were aware of both the actual dimensions of
the vacuolar system and the large quantity of membrane that was con
tinually flowing into the cell (Steinman et al., 1976). During each 60
seconds, 3.1 % of the total surface area of the macrophage (830 µm2)
was entering the cytoplasm as vesicles or a total surface area each 33
minutes. Since the individual plasma membrane polypeptides had half
lives of 24-30 hours (Kaplan et al., 1979), one could discount any
extensive digestion and synthesis to explain the results. A more likely
possibility was that vesicle membrane was being reutilized and cycled
back to the cell surface. We were assuming in some of these specula
tions that a representative sample of polypeptides was present in the
vesicles an_d were cycling in unison. This assumption wa� by no means
clear and in fact had been challenged by a number of authors.
A more definitive technique was required to follow the circuitry of a
large group of plasma membrane polypeptides. This was accomplished
utilizing the basic lactoperoxidase (LPO) iodination method developed
by Hubbard and Cohn (1972). For this purpose, however, LPO was
covalently coupled to carboxylated polystyrene latex beads via a water
soluble carbodiimide, yielding a particle that could be rapidly estab
lished within the secondary lysosome (Muller et al., 1980a,b). In the
presence of glucose oxidase-generated hydrogen peroxide and iodide
isotopes, rapid labeling occurred on the luminal surface of secondary
lysosomes with only trace labeling of contents. This was carried out at
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4°C, minimizing membrane movement and resulting in the lysosomal
localization of radioactive grains on electron microscopic autoradiogra
phy. As the temperature was raised to 37 °C, a rapid flow of grains took
place to the cell periphery, and at 30 minutes they were randomized on
both the superior and inferior surfaces.
Similar experiments were then carried out to label specifically either
the exteriorly disposed surface of the plasma membrane or the newly
formed pinocytic vesicles (Mellman et al., 1980). The polypeptide
composition of each of the members of the vacuolar system were com
pared, i.e., plasma membrane, pinosome, and secondary lysosome. On
single-dimension, gradient SDS gels, approximately 24 iodinated poly
peptides were easily discernible on each of the three organelles, and
these were virtually indistinguishable. More recently Muller et al.
(1983) have compared the labeled plasma membrane and secondary
lysosome on two-dimensional isoelectric focusing-SOS systems. Again
no distinctions between the two membranes are apparent. Finally, ex
amination of more "minor" membrane proteins detected with mono
clonal antibodies indicates that the pinosome and secondary lysosome
membrane are representative samples of the plasma membrane. In Fig.
1, therefore, the flow or cycling process represents a membrane con
tinuum. connected by means of extensive membrane fusions.
The above synthesis of these results does not, however, preclude that
receptor-mediated events could not lead to higher concentration of
given polypeptides in the system. One such situation occurs with the
Fen receptor of murine cells, which recognizes immune complexes.
This receptor has been purified by Mellman and Unkeless (1980), and
monoclonal and polyclonal antibodies were prepared against various
epitopes expressed on both the exterior and cytoplasmic face of this
transmembrane molecule. One antibody in particular recognizes the
receptor on the macrophage surface even after its active site has been
occupied (Mellman et al., 1983). This has allowed us to follow the
internalization, cycling, and degradation of the receptor in the presence
and in the absence of ligands of various valences. Turnover of the
receptor was compared to four other exteriorly expressed unrelated
antigens for which we had monoclonal probes. In the absence of an Fe
ligand, each of the plasma membrane components had similar half-lives
and expression in the vacuolar apparatus. However, in the presence of
heavily opsonized erythrocyte ghosts about 50% of the Fe receptors
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were occupied internalized, and cleared from the surface. Subse
quently, both the receptor and ligand were rapidly digested-the recep
tor demonstrating a half-life of only 2 hours under these conditions. In
contrast, other membrane antigens retained their normal expression and
turnover, which was more than 20 hours. Reexpression of the Fe recep
tor was slow and in keeping with new synthesis.
The focal ablation of a receptor from a cycling membrane system
requires rather selective mechanisms. We believe that this does not take
place at the plasma membrane by the generation of a coated vesicle of
restricted composition. Certainly, the receptor may be clustered and
enriched in this structure, but on a basal level of other membrane
polypeptides. We think it more likely that selective degradation occurs
within the secondary lysosomal compartment. Two possible mecha
nisms are suggested in Fig. 3. Both are based upon the movement and
clustering of the receptor in the plane of the membrane-a process that
occurs with ease, as demonstrated by Silverstein and his colleagues. On
the left, receptor aggregation leads to its local accumulation similar to
the capping phenomenon in B lymphocytes. This in tum initiates the
formation of an autophagic vacuole and a multivesicular body, both of
which are commonly encountered in macrophage cytoplasm (Hirsch et
al., 1968). The other mechanism would be shedding of the clustered
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Fie. 3. Mechanisms for the selective intracellular degradation of a receptor-ligand
complex.
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· receptor into the lumen and digestion. In both instances the receptor
would be selectively removed from the recycling pool of membrane.
IV.

THE MACROPHAGE AS A MAJOR SECRETORY CELL

Macrophages that enter the tissues or find themselves attached to the
wall of sinusoids are long lived and maintain significant synthetic prop
erties. Within the last decade our attention has been focused on the wide
range of potentially important macromolecules that these cells release or
secrete into their environment (Table I). Almost all these experiments
have dealt with cultured cells, which are either exposed to a variety of
stimuli or in different states of activation.
One is immediately struck by the wide range and diversity of this list
of products that may be employed in tissue injury, wound healing, and
tissue remodeling (Nathan et al., 1980a,b). Some of my colleagues now
refer to the macrophage as the "circulating hepatocyte." This analogy
although somewhat facetious, nevertheless focuses on the importance of
an emigrating, mobile population with this potential.
Our initial studies on macrophage secretion dealt with what has
turned out to be one of the two or three bulk secretory products, i.e.,
Iysozyme (Gordon et al., 1974). This enzyme is produced constitutively
by most populations of mononuclear phagocytes. Many of the products
are solely produced, or have their rate of secretion enhanced, under
conditions of macrophage activation. This process, which is brought
about both by nonspecific inflammatory environments as well as specif
ic lymphoid products, has been reviewed (Cohn, 1978). Although our
original concepts were biased toward enhancement of function, we now
know, as outlined in Table II, that important molecules are lost or
modulated. In particular, the striking depression in the levels of arach
idonate metabolites, certain ectoenzymes, and plasma membrane anti
gens are noteworthy.
Many questions remain concerning the secretion of these products.
What is the species variation in both qualitative and quantitative ex
pression? What is their temporal sequence? Are there selective triggers,
and can a cell return to a resting state to be stimulated in the future?
Certainly these and other related queries are of concern in understanding
the complexities of inflammation.

TABLE I
SECRETORY PRODUCTS OF MONONUCLEAR PHAGOCYTES THAT MODULATE THE
INFLAMMATORY AND IMMUNE RESPONSES

Complement components
Cl
C4
C2
C3

cs

Factor B
Factor D
Properdin
C3b inactivator
f31H

Coagulation factors
X
IX
VII
V
Thromboplastin
Prothrombin
Prothrombinase
Other enzymes
Lysozyme 0
Neutral proteases
Plasminogen activator
Collagenase
Elastase
Angiotensin-convertase
Acid hydrolases
Proteases
Lipases
Ribonucleases (deoxy)
Phosphatases
Glycosidases
Sulfatases
Arginase
Lipoprotein lipase

a Major bulk products.

Enzyme Inhibitors
Plasmin inhibitors
a2-Macroglobulin

Chemotactic factors
For neutrophils
For fibroblasts

Binding Proteins
Transferrin
Transcobalamin II
Fibronectin
Apolipoprotein E 0

Factors regulating syn
thesis of proteins by
other cells
Hepatocytes
Serum amyloid A
Haptoglobin
Synovial-lining cells
Collagenase
Prostaglandins
Plasminogen activator
Adipocytes
Lipoprotein lipase

Oligopeptides
Glutathione
Bioactive lipids
Arachidonate metabolites
Prostaglandin E 2
Prostaglandin F2a
6-Keto-prostaglandin
F 1a (from pros
tacyclin)
Thromboxane A2
Leukotrienes B, C, D,
E (including SRS-A)
Monohydroxy
eicosatraenoic acids
(5-; 12-; 15-)
Dihydroxyeicosatra
enoic acids
Platelet-activating factors
Nucleosides and metabolites
Thymidine
Uracil
Uric acid
Reactive metabolites of
oxygen
Superoxide anion
Hydrogen peroxide
Hydroxyl radical
Singlet oxygen (?)

Factors promoting
growth of:
Lymphocytes (T and B
cells)
Myeloid precursors (colo
ny-stimulating factors,
factor inducting mono
cytopoiesis)
Erythroid precursors
Fibroblasts
Capillaries (angiogenesis
factor)
Factors inhibiting growth
of:
Lymphocytes
Myeloid precursors
Tumor cells
Viruses (interferon, a, 13)
Listeria monocytogenes
Other hormone-like fac
tors
Endogenous pyrogens
(two Mr species)
Insulin-like activity
Thymosin B4
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TABLE II
PROPERTIES OF ACTIVATED MACROPHAGES

Cell surface
determinants

Metabolic

Structural

Endocytosis

Elevated
Spreading
Ruffled membranes
Polarization
Secondary lysosomes

Glucose cons.
02 cons.
HMP shunt

Ia antigen
Alkaline PDE I

02
OH-

C3b mediated
Fluid pinocytosis
EA ingestion

H 202
Secretion of pro
teinases, etc.
Depressed
Cyclooxygenase
5 '-Nucleotidase
Mannose receptor
PGE2
Antigen F4/80
Prostacyclin
Lipoxygenase
Leukotrienes
Mono HETEs
a HMP, hexose monophosphate; PDE, phosphodiesterase; PGE, prostaglandin E;
HETE, I 2L-hydroxy-5, I, I 0, 14-eicosatetranoic acid.

V.

THE MACROPHAGE AS AN EFFECTOR CELL

A. The Intracellular Milieu
It was apparent from the earlier work of Rich, Lurie, and Danenberg,
Suter and Mackaness and North, that the activation of macrophages
during infection with intracellular microbial pathogens lead to an en
hanced microbicidal state in the animal. This was followed by the
elegant demonstrations of the important link between sensitized T cells,
the production of lymphokines, and the activation of macrophages by
Mackaness, North, David, and Bloom. Only more recently have we
begun to understand the underlying mechanisms that lead to intra
cytoplasmic killing and extracellular cytotoxic reactions.
Our progress in this area was related to the availability of large, easily
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scored targets that replicated only within living host cells. In addition,
our ability to manipulate relatively homogeneous populations of resi
dent, elicited, and activated cells under the defined conditions of an in
vitro environment allowed us to approach biochemical distinctions.
These methodological advances were aided by the extensive knowledge
of n�utrophils, oxidases, the generation of oxygen intermediates and
myeloperoxidase. This system, which lead to microbial halogenation or
the "Klebanoff pathway," set the groundwork for examining the mac
rophage. It soon became evident that macrophages in the resting state
failed to generate appreciable quantities of either superoxide anion
(02 -) or hydrogen peroxide (H20 2 ) (Johnston et al., 1981; Nathan and
Root, 1977). However, when harvested from animals undergoing infec
tion with Listeria or bacillus Calmette-Guerin they produced large
amounts of both products. To examine this modulation in more detail,
we chose the in vitro environment and the host-parasite interaction of
Trypanosoma cruzi tryposmastigotes with resident murine peritoneal
macrophages (Nogueira and Cohn, 1978). In the presence of usual
media these organisms replicated free in the cytoplasm of the mac
rophage, having lysed the endocytic vacuole shortly after ingestion
(Nogueira and Cohn, 1976). After 72 hours the resulting amastigotes
ruptured their hosts and initiated another cycle of infection.
The addition of supernatants from specific antigen-triggered sen
sitized T cells (lymphokines) lead to a dramatic increase in the ability of
the macrophage to destroy the trypomastigotes (Nogueira and Cohn,
1978). At concentrations as low as 2% and treatment from 24 hours in
vitro, resident macrophages took on the structural properties of the
activated mode and sterilized the intracellular milieu. Organisms ini
tially free in the cytoplasm at the onset_ of lymphokine therapy were seen
in various stages of degeneration within newly formed autophagic vac
uoles. Subsequently, we extended this analysis to Toxoplasma and
Leishmania with basically similar results (Murray et al., 1979).
One could now correlate the formation of toxic oxygen intermediates
with the microbicidal process. A clear-cut association between the for
mation of H 2 02 and intracytoplasmic killing was established in acti
vated cells of both the intact mouse and macrophages exposed to lym
phokines in vitro (Nathan et al., 1979a,b,c). In addition, parasites
cultured in the presence of variable fluxes of glucose oxidase-generated
H 20 2 were appropriately sensitive to this reagent. Monocytes rapidly
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lose their endogenous supply of azurophil granule localized my
eloperoxidase during maturation to the macrophage. Therefore, the mi
crobicidal process of activated macrophages appears to depend largely
on reactive oxygen intermediates of which H20 2 is only one example.
This is not to exclude other factors such as proteases, which may in fact
operate through an oxygen-dependent mechanism (Johnston et al.,
1981).
B. The Extracellular Milieu
Much of the hydrogen peroxide generated by activated macrophages
is liberated into the extracellular milieu. Here depending upon local
concentrations it can destroy sensitive eukaryotic targets including tu
mor cells (Nathan et al., l 979a,b). As in the case of intracellular tar
gets, toxic oxygen intermediates are responsible for much of the activity
of macrophages against neoplastic cells. A number of studies have
demonstrated the oxygen dependence of the process and its correlation
with the formation of H2 0 2 (Nathan et al., 1980a,b). It seems likely
that H2 02 secretion may be vectorial and limited to the membrane zone
exposed to the inducing stimulus. Secretion may then occur within
lacunae, separated from the general environment and reminiscent of the
bone absorbing events carried out by osteoclasts.
Both tumor cells and intracellular microbes demonstrate considerable
variation in their sensitivity to oxygen intermediates (Nathan et al.,
1980a,b). With murine tumor cells this is best correlated with their
content of scavengers of oxygen radicals and in particular with cellular
levels of gluthathione (Arrick et al., 1982). Figure 4 illustrates some of
the pathways implicated in the maintenance of reduced glutathione
(GSH). Factors including oxygen per se and oxidizable substrates
(glucose) influence GSH levels. Figure 4 includes more specific agents
that inhibit synthesis (buthionine sulfoximine), GSH peroxidase (se
lenium deficiency), GSSG reductase (BCNU) and shows electrophiles
that complex GSH (CDNB + SLs). Each to a greater or lesser extent
can sensitize tumor cells for an oxidative attack and may shift the dose
response titration with H2 0 2 by as much as 50- to 100-fold (Arrick et
al., 1982). One may also kill tumor cells in the peritoneal cavity by
generating high local concentrations of H 2 02 via a glucose ox
idase-latex bead (Nathan and Cohn, 1981). It is of interest that the rate-
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limiting reactant under these conditions is molecular oxygen, and tu
mor-killing can be enhanced by exposing animals to a high p02. Both
the generation of local concentrations of toxic oxygen intermediates and
the inhibition of tumor scavenging systems may well have a place in the
therapeutic armamentarium of the future.
VI.

THE MACROPHAGE AS A MEDIATOR OF INFLAMMATION

The more classic view has considered the macrophage only in terms
of chronic, granulomatous forms of inflammation. There is now rather
compelling evidence that suggests important roles of macrophages in
immediate forms of allergy as well. These include the presence of large,
constant tissue pools and the production of potent metabolites that can
influence the microvasculature and smooth muscle-containing struc
tures. One of the more interesting concerns the metabolites of arach
idonic acid (20:4), an unsaturated fatty acid present in macrophage
membrane phospholipids at the high level of 25 mol% . Exposure of
macrophages to particulate stimuli leads to the release of as much as
60-70% of the total arachidonate as metabolites of both the cycloox-
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ygenase and lipoxygenase pathways (Scott et al., 1980). The products
of mouse populations is outlined in Table III (Rouzer et al., 1980a,
1982). It is apparent that large amounts are formed in response to
immune complexes of IgG and IgE. Phagocytosis per se is not required;
merely the interaction of a multivalent ligand with the Fe receptor on the
cell surface is sufficient to trigger the secretory event (Rouzer et al.,
1980b). This is a new role for the Fe receptor in addition to its better

TABLE III
THE ARACHIDONATE METABOLITES OF MURINE MACROPHAGE POPULATIONS

Macrophage source
Resident peritoneal

Stimulus
Zymosan

IgG immune complexes
IgE immune complexes
IgE immune complexes
C. parvum-elicited
peritoneal

Zymosan

Interstitial pulmonary

Zymosan

Product

Amount
(pmol/ 107 cells)

PGE2
6-Keto-PGF 1a
HETEs
Leukotriene C
PGE 2
6-Keto-PGF Ia
Leukotriene C
PGE2
6-Keto-PGF 1a
Leukotriene C
PGE2
6-Keto-PGF I a
Leukotriene C
PGE2

14,000
6,000
3,300
4,500
5,400
13,000
2,000
5,400
13,000
2,000
4,800
8,200
1,100
3,000

6-Keto-PGF 1a
TXB2
HETEs
Leukotriene C
PGE2
6-Keto-PGF 1a
TXB2
HETEs
Leukotriene C
Unidentified

150
650
850
95
2,300
1,100
1,500
5,600
3,800
3,000

a PGE, PGF 1a, prostaglandins, E 1 and F 1a; IgG, immunoglobulin G; HETE, 12 L
hydroxy-5,8,10,14-eicosatetranoic acid; TXB, thromboxane B.
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known activity for initiating phagocytosis. A second point is that the
process of activation leads to a marked depression in the production of
arachidonate metabolites (Scott et al., 1982b). At present the mecha
nisms that modulate the phospholipases-and therefore the release of
membrane 20:4 as well as the metabolic enzymes responsible for the
production of the active metabolites-are unclear. One can consider
that such regulating events might well influence the overall inflamma
tion process.
Although specific membrane stimuli are required for the production
of cyclooxygenase and lipoxygenase products from the esterified 20:4
of phospholipids, free 20:4 can be extensively metabolized without a
stimulus (Scott et al., 1982a,b). Large quantities of products are con
tinually formed from the free fatty acid via what has been called the
exogenous pathway.
VII.

MACROPHAGE AND CELL-MEDIATED IMMUNITY

There is little doubt that macrophages are important effector cells in
immune responses characterized by delayed forms of hypersensitivity,
nor that their secretory products such as prostaglandin E2 may suppress
the function of lymphoid cells (Nussenzweig et al., 1980). There is
even some unanimity of opinion that they may on occasion support the
growth of lymphoid cells in the artificial test tube environment. What is
less clear is their role as ''processors'' or ''presenters'' of antigen for
the stimulation of T cells. We suspect that in fact macrophages play
rather minor roles in this process, their preeminence being usurped by
an adherent cell type that for years has been hiding among the forest of
macrophage ruffles. This is the dendritic cell, a novel character in
immune responses, which has been so elegantly isolated and charac
terized by Steinman and his colleagues (Steinman and Nussenzweig,
1980). The dendritic cell constitutively expresses large amounts of Ia
antigen on its surface and serves as the most potent stimulator of the
allogeneic and syngeneic mixed lymphocyte reaction (MLR) and other
forms of reactions that lead to T-cell replication and the formation of
cytotoxic T cells. Monoclonal antibodies specific for dendritic cells and
C' can destroy the cell in mixed spleen populations and subsequently
ablate the MLR, whereas similar studies employing anti-monocyte
monoclonals do not alter the allogeneic MLR.
Studied initially in the mouse, an analogous cell type with similar
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properties is present in the rat and in man as well. In the human species
it is present in small numbers in the circulation and has been purified by
Van Voorhis et al. (1982). It is clear that the dendritic cell, serving as a
passenger leukocyte in transplant studies, will have a major impact on
transplantation and in the control of graft rejection. As the reagents for
its study become more readily available, immunologists will cease their
practice of referring to "adherent" populations and begin to distinguish
between members of the mononuclear phagocytes and the dendritic
cells.
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